From islet of Langerhans transplantation to the bioartificial pancreas.

Thierry Berney, Charles H Wassmer, Fanny Lebreton, Kevin Bellofatto, Laura Mar Fonseca, Juliette Bignard, Reine Hanna, Andrea Peloso, Ekaterine Berishvili

Presse medicale (Paris, France : 1983) 2022 Dec

filter terms:

Type 1 diabetes is a disease resulting from autoimmune destruction of the insulin-producing beta cells in the pancreas. When type 1 diabetes develops into severe secondary complications, in particular end-stage nephropathy, or life-threatening severe hypoglycemia, the best therapeutic approach is pancreas transplantation, or more recently transplantation of the pancreatic islets of Langerhans. Islet transplantation is a cell therapy procedure, that is minimally invasive and has a low morbidity, but does not display the same rate of functional success as the more invasive pancreas transplantation because of suboptimal engraftment and survival. Another issue is that pancreas or islet transplantation (collectively known as beta cell replacement therapy) is limited by the shortage of organ donors and by the need for lifelong immunosuppression to prevent immune rejection and recurrence of autoimmunity. A bioartificial pancreas is a construct made of functional, insulin-producing tissue, embedded in an anti-inflammatory, immunomodulatory microenvironment and encapsulated in a perm-selective membrane allowing glucose sensing and insulin release, but isolating from attacks by cells of the immune system. A successful bioartificial pancreas would address the issues of engraftment, survival and rejection. Inclusion of unlimited sources of insulin-producing cells, such as xenogeneic porcine islets or stem cell-derived beta cells would further solve the problem of organ shortage. This article reviews the current status of clinical islet transplantation, the strategies aiming at developing a bioartificial pancreas, the clinical trials conducted in the field and the perspectives for further progress. Copyright © 2022 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Citation

Thierry Berney, Charles H Wassmer, Fanny Lebreton, Kevin Bellofatto, Laura Mar Fonseca, Juliette Bignard, Reine Hanna, Andrea Peloso, Ekaterine Berishvili. From islet of Langerhans transplantation to the bioartificial pancreas. Presse medicale (Paris, France : 1983). 2022 Dec;51(4):104139